MBED Stock Overview
The Arab Pesticides & Veterinary Drugs Mfg. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
The Arab Pesticides & Veterinary Drugs Mfg. Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ2.62 |
| 52 Week High | د.أ2.70 |
| 52 Week Low | د.أ2.04 |
| Beta | 0.12 |
| 11 Month Change | 4.38% |
| 3 Month Change | 6.94% |
| 1 Year Change | 27.18% |
| 33 Year Change | 9.62% |
| 5 Year Change | 81.94% |
| Change since IPO | 10.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| MBED | JO Chemicals | JO Market | |
|---|---|---|---|
| 7D | 1.9% | -0.5% | 0.5% |
| 1Y | 27.2% | -3.8% | 3.2% |
Return vs Industry: MBED exceeded the JO Chemicals industry which returned -3.8% over the past year.
Return vs Market: MBED exceeded the JO Market which returned 3.3% over the past year.
Price Volatility
| MBED volatility | |
|---|---|
| MBED Average Weekly Movement | 2.4% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JO Market | 5.8% |
| 10% least volatile stocks in JO Market | 1.3% |
Stable Share Price: MBED has not had significant price volatility in the past 3 months compared to the JO market.
Volatility Over Time: MBED's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Mazen Wathaifi | www.mobedco.com |
The Arab Pesticides & Veterinary Drugs Mfg. Co. PLC, together with its subsidiaries, manufactures and sells pesticides and veterinary medicines in Jordan and internationally. The company was founded in 1991 and is based in Amman, Jordan.
The Arab Pesticides & Veterinary Drugs Mfg. Co. Fundamentals Summary
| MBED fundamental statistics | |
|---|---|
| Market cap | د.أ43.23m |
| Earnings (TTM) | د.أ5.52m |
| Revenue (TTM) | د.أ33.67m |
7.8x
P/E Ratio1.3x
P/S RatioIs MBED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MBED income statement (TTM) | |
|---|---|
| Revenue | د.أ33.67m |
| Cost of Revenue | د.أ22.21m |
| Gross Profit | د.أ11.46m |
| Other Expenses | د.أ5.93m |
| Earnings | د.أ5.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 34.03% |
| Net Profit Margin | 16.40% |
| Debt/Equity Ratio | 14.2% |
How did MBED perform over the long term?
See historical performance and comparison